Considerations for the development of guidance on dose level selection for developmental and reproductive toxicity studies

Regul Toxicol Pharmacol. 2024 Feb 23:105585. doi: 10.1016/j.yrtph.2024.105585. Online ahead of print.ABSTRACTIn 2022, the European Chemicals Agency issued advice on the selection of high dose levels for developmental and reproductive toxicity (DART) studies indicating that the highest dose tested should aim to induce clear evidence of reproductive toxicity without excessive toxicity and severe suffering in parental animals. In addition, a recent publication advocated that a 10% decrease in body weight gain should be replaced with a 10% decrease in bodyweight as a criterion for dose adequacy. Experts from the European Centre for Ecotoxicology and Toxicology of Chemicals evaluated these recent developments and their potential impact on study outcomes and interpretation and identified that the advice was not aligned with OECD test guidelines or with humane endpoints guidance. Furthermore, data analysis from DART studies indicated that a 10% decrease in maternal body weight during gestation equates to a 25% decrease in body weight gain, which differs from the consensus of experts at a 2010 ILSI/HESI workshop. Dose selection should be based on a biological approach that considers a range of other factors. Excessive dose levels that cause frank toxicity and overwhelm homeostasis should be avoided as they can give rise to effects that are not relevant to human health assessments.PMID:38403008 | DOI:10.1016/j.yrtph.2024.105585

Source: Regulatory Toxicology and Pharmacology : RTP - February 25, 2024 Category: Toxicology Authors: R W Lewis A K Andrus J Arroyo S Brescia P A Botham M Corvaro G P Daston T Hofmann C Rodriguez F Sewell B van Ravenzwaay K Wiench S Marty Source Type: research